Formulated Curcumin Exerts Potent Anti-Influenza Activity by Inhibition of Akt Activation and Viral Genome Replication
Intervirology · 2026
DOI: 10.1159/000552999 ↗Kurz gefasst
Fachartikel in der Zeitschrift Intervirology, 2026. Verfasst von Hui-Ming Chang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Microbiology and Public Health, College of Veterinary Medicine, National Chung Hsing University, Taichung, Taiwan. Hauptthemen laut MEDLINE: Curcumin, Virus Replication, Antiviral Agents, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Influenza A viruses (IAVs) cause not only seasonal epidemics but also pandemics in humans. The emergence of H5N1 variants resistant to oseltamivir highlights the need to develop new antiviral therapeutic strategies. Accumulated evidence has indicated the potent anti-influenza activity of curcumin (Cur). Nevertheless, the unsatisfactory bioavailability of Cur limits its clinical use.
Methods
In the present study, the anti-influenza activity and underlying mechanism of encapsulated Cur in nanoparticle form, referred to as Cur-micelle (Cur-M), were evaluated.
Results
Our results demonstrated that, as with native Cur treatment, Cur-M treatment remarkably reduced IAV infection. Interestingly, Cur-M significantly inhibited IAV infectivity post-viral entry, while treatment with Cur alone showed no effect, as demonstrated by differences in plaque formation ability. By monitoring intracellular processing, including the signaling pathway required for IAV propagation and the critical viral replication step, we discovered that viral RNA replication and the activation of Akt signaling were significantly suppressed under Cur-M treatment.
Conclusion
This study demonstrates for the first time that Cur-M interferes with intracellular processes required for influenza virus infection, highlighting its potential for further evaluation in both cell-based and in vivo systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Institute of Microbiology and Public Health, College of Veterinary Medicine, National Chung Hsing University, Taichung, Taiwan.
- Department of Chemistry, National Chung Hsing University, Taichung, Taiwan.
- Department of Animal Healthcare, Hungkuang University, Taichung, Taiwan.
- Department of Biochemistry, School of Medicine, Boston University, Boston, Massachusetts, USA.
- Department of Biomedical Sciences and Engineering, Institute of Systems Biology and Bioinformatics, National Central University, Taoyuan, Taiwan.
- Graduate Institute of Microbiology and Public Health, College of Veterinary Medicine, National Chung Hsing University, Taichung, Taiwan, wlhsu@dragon.nchu.edu.tw.
Zitieren
APA
Chang, H. M., Lai, P. S., Li, C. Z., Lin, F. Y., Chen, D. Y., Tsai, R. S., Ou, S. C., Ma, N., & Hsu, W. L. (2026). Formulated Curcumin Exerts Potent Anti-Influenza Activity by Inhibition of Akt Activation and Viral Genome Replication. Intervirology. https://doi.org/10.1159/000552999
Vancouver
Chang HM, Lai PS, Li CZ, Lin FY, Chen DY, Tsai RS, et al. Formulated Curcumin Exerts Potent Anti-Influenza Activity by Inhibition of Akt Activation and Viral Genome Replication. Intervirology. 2026. doi:10.1159/000552999
BibTeX
@article{Chang2026,
author = {Chang, Hui-Ming and Lai, Ping-Shan and Li, Cun-Zhao and Lin, Fong-Yuan and Chen, Da-Yuan and Tsai, Ruei-Sheng and Ou, Shan-Chia and Ma, Nianhan and Hsu, Wei-Li},
title = {Formulated Curcumin Exerts Potent Anti-Influenza Activity by Inhibition of Akt Activation and Viral Genome Replication},
journal = {Intervirology},
year = {2026},
doi = {10.1159/000552999}
}
EUVIMED